Magdi Khalil, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 11 Grove St, Booth House, New Milford, CT 06776 Phone: 860-354-5511 Fax: 860-210-2641 |
News Archive
Preliminary results from an ongoing, large-scale study by Yale School of Medicine researchers shows that oxytocin - a naturally occurring substance produced in the brain and throughout the body- increased brain function in regions that are known to process social information in children and adolescents with autism spectrum disorders (ASD).
Expanding the program for low-income residents would help bring new revenue to the hospitals. Meanwhile, supporters of Medicaid expansion offer a new proposal in Nebraska and a young man in Utah diagnosed with cancer faces treatment problems because he lost his Medicaid coverage.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has applied to the U.S. Food and Drug Administration for orphan drug designation for ALS-886, a novel therapy to reduce and prevent tissue damage, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that results of a Phase 1 clinical study of CRLX101 (formerly IT-101), Cerulean's lead clinical development candidate, and pre-clinical data on Cerulean's development candidate, CRLX288, were presented at the American Chemical Society National Meeting & Exposition, ongoing in Boston, Massachusetts.
The study, which looked at the long-term effectiveness of anti-obesity medications, found that three drugs recommended for long-term use - orlistat, sibutramine and rimonabant, reduced weight by less than 5kg (11 pounds). This equated to a loss of less than 5% of total body weight.
› Verified 5 days ago